Table 1.
Patients (74) | Control (28) | P-value | |
---|---|---|---|
Apa I | 14 (18.9%) | 16 (57.1%) | < 0.05 |
Taq I (1st site) | 74 (100%) | 28 (100%) | ≥ 0.05 |
Taq I (2nd site) | 14 (18.9%) | 2 (7.1%) | < 0.05 |
Patients (74) | Control (28) | P-value | |
---|---|---|---|
Apa I | 14 (18.9%) | 16 (57.1%) | < 0.05 |
Taq I (1st site) | 74 (100%) | 28 (100%) | ≥ 0.05 |
Taq I (2nd site) | 14 (18.9%) | 2 (7.1%) | < 0.05 |